{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:53:48Z","timestamp":1791395628833,"version":"4.3.3"},"reference-count":83,"publisher":"Elsevier","isbn-type":[{"value":"9780128022726","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.adgen.2014.10.006","type":"book-chapter","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T13:38:17Z","timestamp":1417700297000},"page":"235-262","source":"Crossref","is-referenced-by-count":129,"title":["Gene Electrotransfer Clinical Trials"],"prefix":"10.1016","author":[{"given":"Richard","family":"Heller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loree C.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/156652310791823380","article-title":"Nucleic acids electrotransfer in vivo: mechanisms and practical aspects","volume":"10","author":"Andre","year":"2010","journal-title":"Current Gene Therapy"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1586\/14760584.2013.836903","article-title":"Cancer vaccination by electro-gene-transfer","volume":"12","author":"Aurisicchio","year":"2013","journal-title":"Expert Review of Vaccines"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib3","doi-asserted-by":"crossref","first-page":"e14467","DOI":"10.1371\/journal.pone.0014467","article-title":"In vivo electroporation mediated gene delivery to the beating heart","volume":"5","author":"Ayuni","year":"2010","journal-title":"PLoS One"},{"issue":"155","key":"10.1016\/bs.adgen.2014.10.006_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004414","article-title":"Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses","volume":"4","author":"Bagarazzi","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib5","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2","article-title":"Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial","volume":"72","author":"Belehradek","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0277-5379(91)90065-L","article-title":"Electrochemotherapy of spontaneous mammary tumours in mice","volume":"27","author":"Belehradek","year":"1991","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments","volume":"17","author":"Bodles-Brakhop","year":"2009","journal-title":"Molecular Therapy"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11095-010-0338-9","article-title":"Hydrodynamic gene delivery and its applications in pharmaceutical research","volume":"28","author":"Bonamassa","year":"2011","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/fon.13.235","article-title":"Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy","volume":"10","author":"Cadossi","year":"2014","journal-title":"Future Oncology"},{"key":"10.1016\/bs.adgen.2014.10.006_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3748\/wjg.v11.i10.1496","article-title":"Hepatocyte growth factor gene therapy prevents radiation-induced liver damage","volume":"11","author":"Chi","year":"2005","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.006_bib12","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00262-012-1270-0","article-title":"DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time","volume":"61","author":"Chudley","year":"2012","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"36","key":"10.1016\/bs.adgen.2014.10.006_bib13","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","article-title":"Phase I trial of Interleukin-12 plasmid electroporation in patients with metastatic melanoma","volume":"26","author":"Daud","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00232-013-9534-y","article-title":"Cell-specific targeting strategies for electroporation-mediated gene delivery in cells and animals","volume":"246","author":"Dean","year":"2013","journal-title":"Journal of Membrane Biology"},{"key":"10.1016\/bs.adgen.2014.10.006_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1479-5876-11-62","article-title":"Phase 1 studies of the safety and immunogenicity of electroporated HER2\/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors","volume":"11","author":"Diaz","year":"2013","journal-title":"Journal of Translational Medicine"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.4161\/hv.24702","article-title":"Tolerability of intramuscular and intradermal delivery by CELLECTRA((R)) adaptive constant current electroporation device in healthy volunteers","volume":"9","author":"Diehl","year":"2013","journal-title":"Human Vaccines and Immunotherapy"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/mt.2011.235","article-title":"Safety and tolerability of the Easy Vax clinical epidermal electroporation system in healthy adults","volume":"20","author":"El-Kamary","year":"2012","journal-title":"Molecular Therapy"},{"issue":"37","key":"10.1016\/bs.adgen.2014.10.006_bib18","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.vaccine.2013.06.063","article-title":"DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer","volume":"31","author":"Eriksson","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.006_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/gt.2010.43","article-title":"Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation","volume":"17","author":"Ferraro","year":"2010","journal-title":"Gene Therapy"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/mt.2009.12","article-title":"Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing","volume":"17","author":"Ferraro","year":"2009","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1389200211314030003","article-title":"In vivo DNA electrotransfer for immunotherapy of cancer and neurodegenerative diseases","volume":"14","author":"Fioretti","year":"2013","journal-title":"Current Drug Metabolism"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/156652310791823443","article-title":"Gene electrotransfer to skin; review of existing literature and clinical perspectives","volume":"10","author":"Gothelf","year":"2010","journal-title":"Current Gene Therapy"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.006_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/gt.2012.15","article-title":"Electroporation-mediated gene transfer directly to the swine heart","volume":"20","author":"Hargrave","year":"2013","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-009-9141-y","article-title":"Multifunctional nanocomplexes for gene transfer and gene therapy","volume":"26","author":"Hart","year":"2010","journal-title":"Cell Biology and Toxicology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/hum.2009.065","article-title":"Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array","volume":"21","author":"Heller","year":"2010","journal-title":"Human Gene Therapy"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.006_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1089\/hum.2006.17.890","article-title":"In vivo electroporation for gene therapy","volume":"17","author":"Heller","year":"2006","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(96)00590-X","article-title":"In vivo gene electroinjection and expression in rat liver","volume":"389","author":"Heller","year":"1996","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W","article-title":"Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin","volume":"83","author":"Heller","year":"1998","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib29","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1158\/1078-0432.CCR-05-2727","article-title":"Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model","volume":"12","author":"Heller","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.adgen.2014.10.006_bib83","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/156652310791823489","article-title":"Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma","volume":"10","author":"Heller","year":"2010","journal-title":"Curr Gene Ther"},{"issue":"Suppl. 5","key":"10.1016\/bs.adgen.2014.10.006_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1469-0691.12553","article-title":"A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation","volume":"20","author":"Hooper","year":"2014","journal-title":"Clinical Microbiology and Infection"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/hum.2006.17.362","article-title":"In vivo liver electroporation: optimization and demonstration of therapeutic efficacy","volume":"17","author":"Jaichandran","year":"2006","journal-title":"Human Gene Therapy"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.006_bib33","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.006_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jps.21024","article-title":"Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide","volume":"97","author":"Kawakami","year":"2008","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.adgen.2014.10.006_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4614-9632-8_24","article-title":"Evolution of electroporated DNA vaccines","volume":"1121","author":"Keane-Myers","year":"2014","journal-title":"Methods in Molecular Biology"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.006_bib36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/CVI.00327-12","article-title":"A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4\u00a0responses toward the alpha4beta7-binding V2 loop of HIV gp120 in healthy volunteers","volume":"19","author":"Kopycinski","year":"2012","journal-title":"Clinical and Vaccine Immunology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1521-2254(199907\/08)1:4<245::AID-JGM49>3.0.CO;2-G","article-title":"Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer","volume":"1","author":"Kreiss","year":"1999","journal-title":"Journal of Gene Medicine"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nature Reviews Genetics"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14728214.11.3.541","article-title":"Emerging vectors and targeting methods for nonviral gene therapy","volume":"11","author":"Lavigne","year":"2006","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.006_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.0022-202X.2004.23309.x","article-title":"Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db\/db mice","volume":"123","author":"Lee","year":"2004","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ccc.2011.04.002","article-title":"Gene therapy for ALI\/ARDS","volume":"27","author":"Lin","year":"2011","journal-title":"Critical Care Clinics"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.006_bib42","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/hum.2009.067","article-title":"DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer","volume":"20","author":"Low","year":"2009","journal-title":"Human Gene Therapy"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/104454903322624966","article-title":"IL-12 gene therapy using an electrically mediated nonviral\u00a0approach reduces metastatic growth of melanoma","volume":"22","author":"Lucas","year":"2003","journal-title":"DNA and Cell Biology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.006_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/mthe.2002.0601","article-title":"IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma","volume":"5","author":"Lucas","year":"2002","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/gt.2009.153","article-title":"Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression","volume":"17","author":"Marshall","year":"2010","journal-title":"Gene Therapy"},{"issue":"24","key":"10.1016\/bs.adgen.2014.10.006_bib46","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.gt.3302383","article-title":"Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model","volume":"11","author":"Marti","year":"2004","journal-title":"Gene Therapy"},{"key":"10.1016\/bs.adgen.2014.10.006_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-59745-194-9_30","article-title":"KGF-1 for wound healing in animal models","volume":"423","author":"Marti","year":"2008","journal-title":"Methods in Molecular Biology"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000025753","article-title":"Gene transfer to intact mesenteric arteries by electroporation","volume":"37","author":"Martin","year":"2000","journal-title":"Journal of Vascular Research"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/0284186X.2011.573626","article-title":"Management of cutaneous metastases using electrochemotherapy","volume":"50","author":"Matthiessen","year":"2011","journal-title":"Acta Oncologica"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib51","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/bjc.1998.388","article-title":"Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy","volume":"77","author":"Mir","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0277-5379(91)90064-K","article-title":"Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses","volume":"27","author":"Mir","year":"1991","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.006_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO Journal"},{"issue":"24","key":"10.1016\/bs.adgen.2014.10.006_bib54","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","article-title":"Gene therapy progress and prospects: nonviral vectors","volume":"9","author":"Niidome","year":"2002","journal-title":"Gene Therapy"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib55","first-page":"1050","article-title":"High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation","volume":"56","author":"Nishi","year":"1996","journal-title":"Cancer Research"},{"issue":"20","key":"10.1016\/bs.adgen.2014.10.006_bib56","first-page":"5059","article-title":"Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo","volume":"59","author":"Niu","year":"1999","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.006_bib57","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/mt.2013.107","article-title":"Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers","volume":"21","author":"Noble","year":"2013","journal-title":"Molecular Therapy"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib58","first-page":"1319","article-title":"Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors","volume":"78","author":"Okino","year":"1987","journal-title":"Japanese Journal of Cancer Research"},{"issue":"233","key":"10.1016\/bs.adgen.2014.10.006_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008177","article-title":"Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear","volume":"6","author":"Pinyon","year":"2014","journal-title":"Science Translational Medicine"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.006_bib60","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1073\/pnas.96.11.6417","article-title":"Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation","volume":"96","author":"Rizzuto","year":"1999","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.006_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.gt.3302435","article-title":"Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation","volume":"12","author":"Sakai","year":"2005","journal-title":"Gene Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Current Opinion in Immunology"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.006_bib63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/hum.2012.229","article-title":"Biosafety features of lentiviral vectors","volume":"24","author":"Schambach","year":"2013","journal-title":"Human Gene Therapy"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.006_bib64","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/gt.2011.34","article-title":"Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver","volume":"18","author":"Song","year":"2011","journal-title":"Gene Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/humc.2012.240","article-title":"Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study","volume":"24","author":"Spanggaard","year":"2013","journal-title":"Human Gene Therapy Clinical Development"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.006_bib66","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.mt.6300314","article-title":"Hydrodynamic gene delivery: its principles and applications","volume":"15","author":"Suda","year":"2007","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0167-4781(91)90162-F","article-title":"In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA","volume":"1088","author":"Titomirov","year":"1991","journal-title":"Biochimica et Biophysica Acta"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.006_bib68","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2011.304","article-title":"Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina","volume":"20","author":"Touchard","year":"2012","journal-title":"Molecular Therapy"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.006_bib69","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/gt.2009.43","article-title":"Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis","volume":"16","author":"Touchard","year":"2009","journal-title":"Gene Therapy"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.006_bib70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/jgm.1517","article-title":"The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins","volume":"12","author":"Touchard","year":"2010","journal-title":"Journal of Gene Medicine"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib71","first-page":"1","article-title":"Viral vectors: a look back and ahead on gene transfer technology","volume":"36","author":"Vannucci","year":"2013","journal-title":"New Microbiologica"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib72","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"Vasan","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib73","doi-asserted-by":"crossref","first-page":"e8816","DOI":"10.1371\/journal.pone.0008816","article-title":"Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B\u2032\/C candidate vaccine","volume":"5","author":"Vasan","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.006_bib74","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/mt.2009.27","article-title":"Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults","volume":"17","author":"Wallace","year":"2009","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.006_bib75","first-page":"46","article-title":"Non-viral gene delivery methods","volume":"14","author":"Wang","year":"2013","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.006_bib76","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/mt.2013.119","article-title":"Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C","volume":"21","author":"Weiland","year":"2013","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.006_bib77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.006_bib78","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2893.2012.01589.x","article-title":"A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy","volume":"19","author":"Yang","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/bs.adgen.2014.10.006_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2051-1426-1-20","article-title":"Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma","volume":"1","author":"Yuan","year":"2013","journal-title":"Journal of Immunotherapy of Cancer"},{"issue":"1\u20132","key":"10.1016\/bs.adgen.2014.10.006_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1567-5394(02)00057-9","article-title":"Clinical evaluation of safety and human tolerance of electrical sensation induced by electric fields with non-invasive electrodes","volume":"56","author":"Zhang","year":"2002","journal-title":"Bioelectrochemistry"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.006_bib81","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.gt.3302936","article-title":"Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation","volume":"14","author":"Zhou","year":"2007","journal-title":"Gene Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.006_bib82","first-page":"246","article-title":"Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy","volume":"54","author":"Zupanic","year":"2007","journal-title":"Neoplasma"}],"container-title":["Advances in Genetics","Nonviral Vectors for Gene Therapy - Physical Methods and Medical Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266014000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266014000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T00:29:39Z","timestamp":1566088179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065266014000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128022726"],"references-count":83,"URL":"https:\/\/doi.org\/10.1016\/bs.adgen.2014.10.006","relation":{},"ISSN":["0065-2660"],"issn-type":[{"value":"0065-2660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}